Followers | 251 |
Posts | 50194 |
Boards Moderated | 47 |
Alias Born | 08/29/2007 |
Tuesday, December 12, 2023 8:58:14 AM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent MOR News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/21/2024 02:07:45 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/17/2024 02:15:12 PM
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 05/16/2024 08:43:50 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/16/2024 02:11:49 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/15/2024 02:09:03 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/13/2024 02:19:53 PM
- MorphoSys AG Reports First Quarter 2024 Financial Results • Business Wire • 04/29/2024 08:01:00 PM
- MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis • Business Wire • 04/11/2024 12:39:00 PM
- MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update • Business Wire • 03/13/2024 08:02:00 PM
- Boeing Faces Strike Threat, Palantir Up 18% After Recording its First Profitable Year, and More • IH Market News • 02/06/2024 11:14:00 AM
- MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study • Business Wire • 12/11/2023 12:31:00 AM
- MorphoSys Trial for Blood-Cancer Treatment Reaches Primary Endpoint • Dow Jones News • 11/20/2023 10:19:00 PM
- MorphoSys’ Phase 3 Study of Pelabresib in Myelofibrosis Demonstrates Statistically Significant Improvement in Spleen Volume Reduction and Strong Positive Trend in Symptom Reduction • Business Wire • 11/20/2023 09:30:00 PM
- MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results • Business Wire • 11/15/2023 09:01:00 PM
- MorphoSys AG Reports Second Quarter and First Half 2023 Financial Results • Business Wire • 08/09/2023 08:01:00 PM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM